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Objective: Although various techniques have been explored for the detection
and quantification of allograft transplant rejection, a practical and reliable
method that is noninvasive is still elusive.
Methods: For our magnetic resonance imaging experiments, we have devel-
oped a new rat model of heterotopic lung transplantation to the inguinal
region. Allogeneic transplants (DA to Brown Norway) were performed with
and without cyclosporine A (INN: ciclosporin) treatment, with syngeneic
transplants (Brown Norway to Brown Norway) serving as controls (n = 6 per
group). Magnetic resonance images were obtained with a gradient echo
method before and after injection of ultra-small superparamagnetic iron
oxide particles.
Results: At day 5, allogeneic transplants without cyclosporine A treatment
showed a grade 4 rejection histologically. A significantly lower magnetic
resonance signal was seen 24 hours after injection of ultra-small super-
paramagnetic iron oxide particles compared with the preinjection image
(346 ± 7.6 vs 839 ± 43.4 arbitrary units; P < .05). Syngeneic transplants
showed no evidence of rejection histologically and no differences in mag-
netic resonance imaging signals between the images before and after injec-
tion of ultra-small superparamagnetic iron oxide particles (863 ± 18.8 vs
880 ± 22.5). Allotransplants treated with cyclosporine A showed a grade 2
rejection histologically. The change in magnetic resonance signals in that
group was small but showed a significant decrease in signal intensity after
injection (646 ± 10.5 vs 889 ± 23.5, P < .05). Immunohistochemistry and
iron staining of the allografts indicated that ultra-small superparamagnetic
iron oxide particles were taken up by the infiltrating macrophages that
accumulated at the rejection site.
Conclusions: We have demonstrated a novel approach for the detection of
acute lung allograft rejection using magnetic resonance imaging coupled
with injection of ultra-small superparamagnetic iron oxide particles. Despite
its limitations, our method might be a first step toward a potential clinical
application. (J Thorac Cardiovasc Surg 2000;120:923-34)
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O rgan transplantation has now been recognized as atherapeutic procedure for end-stage organ failure.
For lung transplantation, the rate of survival and quali-
ty of life of the patients have been improving steadily;
however, several problems are still to be overcome.
Acute and chronic lung rejections continue to be the
major reason for graft loss and contribute significantly
to the morbidity and mortality after transplantation.
Although various techniques for the detection and
quantification of lung allograft rejection have been
explored, practical and noninvasive diagnoses of
acute rejection after transplantation are still elusive.
The technique of biopsy for routine rejection surveil-
lance has contributed to the progressive decline in
deaths as a result of acute rejection. However, this
technique is invasive, costly, and prone to sampling
error. Also, interpretation of biopsy specimens is
somewhat subjective and possibly arbitrary. A num-
ber of noninvasive approaches for detecting lung
transplant rejection have been proposed—an analysis
of bronchoalveolar lavage fluid,1 Doppler measure-
ment of pulmonary circulatory parameters,2 radio-
spirometry,3 pulmonary lymphoscintigraphy,4 high-
resolution computed tomography,5 and detection with
indium 111–labeled lymphocytes.6 However, none of
these approaches has gained widespread clinical use.
A sensitive and noninvasive method of detecting
rejection is still being sought.
Ultra-small superparamagnetic iron oxide (USPIO)
particles enhance relaxation times in magnetic reso-
nance imaging (MRI). This property has been exploit-
ed in the use of USPIO in magnetic resonance lym-
phography,7 where the accumulation of USPIO in the
cytoplasm of macrophages within lymph nodes is
detected, and also in labeling T cells in vitro8,9 for
tracking purposes in vivo.10 Recently, USPIO has been
used for tracking infiltrating renal macrophages in an
experimental model of nephrotic syndrome.11 In a pre-
liminary report, we12 suggested that USPIO particles
are useful to detect the accumulation of macrophages in
a rat model for renal allograft rejection. Conventional
superparamagnetic iron oxide (SPIO) particles, which
are 100 to 1000 nm in diameter, are rapidly taken up by
the mononuclear phagocytic system and cleared from
blood within minutes after intravenous infusion, where-
as USPIO particles are not immediately trapped by the
mononuclear phagocytic system of the liver and spleen.
USPIO particles have a longer half-life of about 2 hours
in blood and are found to be present in lymph nodes.13
In this article, we present a novel MRI method to
detect lung rejection by injection of USPIO particles. It
is a simple, noninvasive, highly sensitive, and safe
method without the use of radioisotopes.
Conventional intra-abdominal heterotopic heart and
lung transplantation in the rat was described originally
by Lee and associates14 and modified by Fox and
Montorsi.15 This conventional model of transplantation
is not suitable for MRI of lungs because of the abdom-
inal and respiratory interference during MR signal
acquisition. For in vivo experimental study, we have
developed a new rat model of heterotopic lung trans-
plantation to the inguinal region so that the MR signal
can be detected effectively, independent of the interfer-
ence of abdominal gas, bowel movement, and respira-
tory motion.
Materials and methods
Animals. Inbred Brown Norway (BN; RT1n) and DA
(RT1a) male rats, 2 to 3 months of age, weighing 220 to 250
g each, were obtained from Harlan Sprague-Dawley, Inc
(Indianapolis, Ind). Animals were housed individually and
provided food and water ad libitum. Animal protocols were
approved by the Institutional Animal Care and Use
Committee of Carnegie Mellon University. All animals
received humane care in compliance with the “Principles of
Laboratory Animal Care” and the “Guide for the Care and
Use of Laboratory Animals,” published by the National
Institutes of Health (NIH Publication No. 96-03, revised
1996).
Heart and lung transplantation. For the operation, both
donor and recipient were anesthetized with an intraperitoneal
injection of pentobarbital sodium (35 mg/kg body weight)
and heparin (500 U/kg body weight). In the syngeneic group,
an en bloc donor heart and lung were taken from a BN rat and
transplanted to another BN rat. In the allogeneic group, a
graft from a DA rat was transplanted to a BN rat. The graft
survival was monitored every day by palpating the trans-
planted heart. One group of allotransplants (n = 6) received
subcutaneous injection of cyclosporine A (CsA; 3 mg/kg)
from day 0 to day 4, whereas the second group of allotrans-
plants (n = 6) and the syngeneic group (n = 6) did not receive
immunosuppressive therapy.
Donor. The anterior chest and abdomen were prepared in
routine surgical fashion with aseptic technique. After the
chest wall was opened, the left lung was ligated and excised.
The azygos vein with the left and right superior venae cavae
were ligated and divided. The descending thoracic aorta was
transected, and 10 mL of cold University of Wisconsin solu-
tion (Dupont Pharma, Wilmington, Del) was infused into the
inferior vena cava until the fluid draining from the aorta was
clear. The inferior vena cava was then ligated and divided.
The ascending aorta was dissected and transected at the por-
tion between the left common carotid artery and the left sub-
clavian artery, followed by ligation and division of the right
brachiocephalic artery and the left common carotid artery.
After removal of the heart and lung from the donor, the right
lung was washed 3 times through the bronchus with
University of Wisconsin solution containing penicillin G. The
grafts were then placed in cold University of Wisconsin solu-
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tion until transplantation. Right before being sutured, the
graft was flushed with cold saline solution to wash out the
University of Wisconsin solution.
Recipient. The left inguinal portion was opened and dis-
sected to make enough space for the transplanted organs. The
left lower part of the abdominal wall was opened in a trans-
verse fashion from the left femoral vessels to the midline. The
abdominal organs were retracted to the right and both the aorta
and the inferior vena cava just beyond the bifurcation were dis-
sected. The vessels were clamped and an appropriate opening
of the aorta was made to receive the aorta of the graft in an end-
to-side fashion with 8-0 polypropylene sutures (Ethicon, Inc,
Somerville, NJ). Rhythmic heartbeats commenced sponta-
neously as the heart and the lung regained circulation after
removal of the clamp. After hemostasis of the surgical field, the
abdominal wall was sutured with 6-0 silk, with care taken to
avoid kinking or obstructing the aorta of the graft.
Preparation of USPIO particles. Dextran-coated
USPIO particles were synthesized in our laboratory accord-
ing to the method of Palmacci and Josephson16 with slight
modifications. Quantitative determination of iron in the
particle suspension was performed for all samples by
means of a spectrophotometric method.17 Iron-core size
was measured by transmission electron microscopy (TEM)
and found to be in the range 4.0 to 7.5 nm. Mean diameter
of whole particles measured by laser light scattering was 
29 ± 3 nm. The MR relaxivities, R1 (spin-lattice relaxation
rate constant 1/T1 per mole of iron in USPIO) and R2 (spin-
spin relaxation rate constant 1/T2 per mole of iron in
USPIO), at 4.7 T were 3.8 × 104 mol–1 · sec–1 and 9.1 × 104
mol–1 · sec–1, respectively. Before infusion, a portion of the
stock suspension of USPIO particles was dialyzed in phos-
phate-buffered saline solution, filter sterilized, and assayed
for iron content.17 The solution was diluted with phos-
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Fig 1. Gradient-echo MR images of macrophage samples in vitro. Cells were prepared as described in the
“Methods” section. Cell concentration of the samples was 2.0 × 106 cells/mL of 5% gelatin in A and B and 0.5 ×
106 cells/mL gelatin in C and D. Cells treated with USPIO particles are shown in A and C and cells not treated
with USPIO particles are shown in B and D.
phate-buffered saline solution to a concentration of 9 µmol
iron per milliliter, and 0.8 mL of the suspension was inject-
ed intravenously for each study.
In vitro MRI and TEM assessment of the uptake of
USPIO particles by macrophages. The ability of macro-
phages to phagocytose USPIO particles was assessed in vitro
by exposing a macrophage cell population to USPIO parti-
cles, followed by MRI. Macrophages were isolated from
spleens of BN rats according to the method of Coligan and
colleagues18 and cultured in reconstituted RPMI 1640 culture
medium (Roswell Park Memorial Institute, Buffalo, NY)
under 5% carbon dioxide at 37°C. The cells were then incu-
bated with USPIO (2 mg iron/10 million cells) for 20 hours
and recovered with 3 washes of phosphate-buffered saline
solution. High-resolution gradient-echo MR images of
labeled macrophage cell phantoms (containing 2 × 106
cells/mL and 0.5 × 106 cells/mL) were obtained with a 7-T,
15-cm horizontal bore Bruker AVANCE DRX MR instrument
equipped with a 4.3-cm microimaging gradient set.8
Acquisition parameters were as follows: repetition time/echo
time (TR/TE) = 1000/30 ms; flip angle = 45°; matrix size =
256 × 256, giving an in-plane resolution of 50 × 50 µm; slice
thickness = 0.1 mm; acquisition bandwidth = 25 kHz; num-
ber of averages = 4; and scan time = 17 minutes. TEM was
performed to determine the location of USPIO particles in the
macrophages. The MRI and TEM studies on macrophages
were carried out by following the procedure described earlier
for the characterization of USPIO-labeled T cells.8
In vivo MRI experiments. MRI measurements in vivo
were carried out on a 4.7-T Bruker AVANCE DRX MR
instrument equipped with a 40-cm horizontal bore supercon-
ducting solenoid. In vivo MR images of transplanted heart-
lung tissue were obtained at indicated time points for 24
hours after infusion of USPIO particles. The imaging
sequence consisted of a gradient echo sequence, triggered to
the electrocardiogram: TR/TE = 1000/10 ms, flip angle =
Ernst angle; slice thickness = 1 mm, field of view = 6.0 cm;
data matrix size = 256 × 130 (zero-filled to 256 × 256); and
scan time = 5 minutes. Electrocardiographic gating was used
to limit artifacts from the heartbeat. The change of MRI sig-
nal intensity was measured in 5 different regions in each
transplanted lung.
Histologic analysis and immunohistochemistry. After
each MR experiment, the transplanted lung was extirpated,
fixed in 4% paraformaldehyde, embedded in paraffin, and
processed for 5-µm sections. Hematoxylin-eosin staining
and Perls’ Prussian blue staining were performed in the
Transplantation Pathology Laboratory of the University of
Pittsburgh Medical Center. Histologic analysis for patho-
logic grading of rejection, which is based on the criteria
established by the International Society for Heart and Lung
Transplantation, was also performed by that laboratory in
a blind manner. Monoclonal anti-rat macrophage antibody
(ED1; Serotec Ltd, Oxford, United Kingdom) and anti-
CD3 antibody (DAKO, Carpenteria, Calif) were used as
the primary antibody for macrophage lineage cells and T
cells, respectively. Immunohistochemistry was carried out
with the ABC staining system (Santa Cruz Biotechnology,
Inc, Santa Cruz, Calif) according to the manufacturer’s
protocol.
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Fig 2. A new heterotopic lung transplantation model suited for MR signal detection. An en bloc heart and right lung
were transplanted to the groin area of the recipient. The gross view of the surgical field is shown in the left panel.
The transplanted heart is indicated by the arrow and the transplanted lung is indicated by the arrowhead. The aorta
of the graft was connected to the abdominal aorta of the recipient. The transplanted grafts were isolated from
abdominal organs by the abdominal wall and put in the subcutaneous tissue. A representative MR image of the allo-
transplant on postoperative day 4 in the coronal plane is shown in the right panel. The area encompassed by the
dotted line is the transplanted graft. The lung is indicated by the arrowhead.
Statistical analysis. The results are presented as mean ±
standard deviation. Nonparametric data were analyzed by the
Mann-Whitney test, and the remaining data were analyzed by
analysis of variance with the use of StatView software (SAS
Institute Inc, Cary, NC).
Results
In vitro MR and TEM properties of USPIO-
labeled macrophages. An in vitro assessment of
macrophage cell phantoms by MRI was performed to
investigate the labeling efficiency of USPIO particles.
MR images of USPIO-labeled and unlabeled macro-
phages in 5% gelatin are shown in Fig 1. In Fig 1, A, a
phantom consisting of 2 × 106 cells/mL of macro-
phages labeled with USPIO showed numerous dark
spots in MRI, whereas a phantom with the same num-
ber of unlabeled macrophages in Fig 1, B, did not show
any spots. Fig 1, C and D, showed USPIO-labeled and
unlabeled samples, respectively, with a concentration
of 0.5 × 106 macrophages/mL. On the basis of our pre-
vious USPIO-labeled T-cells result,8,12 we believe that
each dark spot in the labeled samples represents a sin-
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Fig 3. MR images showing the effect of USPIO particle infusion in an allotransplant. MR images of the coronal
view of the graft are shown in A and B, and the sagittal view of the graft is shown in C and D. The MR images of
the graft on postoperative day 4 before USPIO infusion are at A and C, and the images taken 24 hours after infu-
sion are at B and D. The lung is indicated by the arrow in each panel. Representative images are shown.
gle USPIO-labeled macrophage (Fig 1, A and C). The
density of these dark spots appeared to be dependent on
the concentration of macrophages. TEM results indi-
cated that the labeling efficiency of macrophages by
USPIO particles in vitro was nearly 80% (results not
shown).
In vivo MR experiments on the lung transplanta-
tion model. For in vivo MR experiments, we have
developed a new rat model of lung transplantation. In
this model, an en bloc heart and lung graft was trans-
planted to the groin area of the recipient to detect MR
signals more effectively, shielded from abdominal and
respiratory interference. Fig 2 showed a gross view of
the surgical area and a typical horizontal MR image of
this model.
Representative MR images of each of the experimen-
tal groups on postoperative day 4 before injection of
USPIO particles and 24 hours after injection are shown
in Figs 3, 4, and 5. A clear decrease in MR signal inten-
sity was demonstrated in the image of the allogeneic
transplanted lung 24 hours after infusion of USPIO par-
ticles compared with the preinfusion signal (Fig 3). In
contrast, there was no significant MR signal change in
the syngeneic transplanted lung (Fig 4) before and 24
hours after USPIO infusion. In the CsA-treated group, a
significant decrease in MR signal was seen in the trans-
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Fig 4. MR images showing the effect of USPIO particle infusion in an isograft. MR images of the coronal view of the graft
are shown. The MR images of the isograft on postoperative day 4 before USPIO infusion are at A and C, and the images
taken 24 hours after infusion are at B and D. The lung is indicated by the arrow in each panel. Representative images are
shown.
planted lung 24 hours after USPIO infusion compared
with the preinfusion signal (Fig 5). Fig 6 summarizes
the MR signals in each group during the experiment. No
significant difference of the MR signal intensity among
the groups was apparent before USPIO infusion.
However, a significant decrease was detected in MR
signal intensity in the allograft group without CsA treat-
ment compared with the isograft group (346 ± 18.5 in
the allograft group vs 863 ± 46.1 in the isograft group;
P < .001) 24 hours after infusion of the USPIO particles
(Fig 6). In addition, a significant decrease in MR signal
intensity was also observed in the group of allografts
treated with CsA compared with the isograft group 
(646 ± 28.5 vs 863 ± 46.1, P < .001). There is a signif-
icant difference in MR signal intensity between allo-
grafts with or without CsA treatment as well (P < .01).
The in vivo half-life of USPIO in blood after infusion
into a rat measured in our laboratory is about 120 min-
utes, which is consistent with the data previously
reported by other laboratories.11,13
Histologic and immunohistochemical analyses of
the lung allografts. Histologic analysis of the graft
showed a significant difference in rejection grades
between the allograft group (all 6 in grade 4) and the
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Fig 5. MR images showing the effect of USPIO particle infusion in the allotransplant treated with cyclosporine A
(CsA). MR images of the coronal view of the graft are shown. The MR images of the transplanted lung on post-
operative day 4 before USPIO infusion are at A and C, and the images taken 24 hours after infusion are at B and
D. The lung is indicated by the arrow in each panel. Representative images are shown.
allograft group with CsA treatment (5 in grade 2, 1 in
grade 3; P = .009).
ED1+ cells and CD3+ cells were detected immuno-
chemically in each allograft from paraffin sections.
ED1+ and CD3+ cells were significantly increased in
the allografts without CsA treatment compared with the
isograft group (Fig 7), whereas in the allografts with
CsA treatment, ED1+ cells were also significantly
increased compared with the isograft.
Perls’ Prussian blue staining in the allografts showed
that the distribution of iron particles correlates well
with ED1+ cells but not with CD3+ cells (Fig 8). Perls’
Prussian blue staining in a high-power field demon-
strated that stained iron particles were observed in the
cytoplasm of macrophages (Fig 9). In addition, few
iron particles and ED1+ cells were found in the
parenchyma of native lungs of the animals or in the
transplanted lung in the syngeneic group. These results
suggest that ED1+ cells are actually involved in the
rejection process.
Taken together, these results indicate that the iron
particles, which are phagocytosed by the macrophages,
modulate MR signal intensity at the rejection site of the
allograft.
Discussion
In these experiments, we have aimed to establish a
new noninvasive method using MRI to detect lung
rejection after transplantation. We show here that
USPIO particles can be used for in vivo labeling of
macrophages, which accumulate at the rejection sites
after allogeneic organ transplantation. Macrophages
labeled with USPIO particles induce a significant
decrease in MR signal intensity in the allograft, and the
decrease has an excellent correlation with the patho-
logic rejection grade.
MRI is a noninvasive diagnostic modality. However,
in the conventional experimental model of heterotopic
lung transplantation, abdominal gas, bowel movement,
and respiratory motion may interfere with the MR sig-
930 Kanno et al The Journal of Thoracic and
Cardiovascular Surgery
November 2000
Fig 6. Summary of the measurements of MR signal intensity in transplanted lungs. MR signal intensity was mea-
sured at 5 different points of the horizontal image of each transplanted lung. Data are indicated as mean ± standard
deviation of the mean, shown as arbitrary units (n = 30, 5 points/rat). Allografts (solid square) showed significant-
ly lower MR intensity compared with isografts (open square) at every time point after USPIO infusion. Allografts
with CsA treatment (diamond) also showed significantly lower MR intensity compared with isografts. There was
also a significant difference between allografts with or without CsA treatment.
nal. Therefore, we developed a new experimental
model in which the graft is transplanted to the groin
area of the recipient animal. We are able to detect MR
signals more effectively in this model, free from any
abdominal and respiratory interference.
Cell-specific imaging is an increasingly important
field of MR imaging.7,9,13 USPIO/SPIO particles have
been used clinically for several years as contrast agents
in the liver and spleen since they accumulate in the
mononuclear phagocyte system of those organs and
induce a decrease in MR signal intensity due to iron
magnetic susceptibility.7 Recently, USPIO particles
have been used for lymphography because of their long
half-life in vivo.11,13 Due to this property in vivo, it is
possible for USPIO particles to be trapped by
macrophages in the whole body, whereas SPIO parti-
cles are mostly trapped by liver and spleen immediate-
ly after infusion. Although USPIO particles have been
used to detect macrophage infiltration in the nephrotic
syndrome model,11 there has been no report applying
this technique to the detection of lung rejection.
Acute and chronic organ rejection remain the most
critical problems to be overcome in caring for trans-
plant recipients. Frequent episodes of acute rejection
are highly associated with the development of chronic
rejection,19 although pathophysiologic mechanisms for
this irreversible process remain unclear. An accurate
diagnosis of rejection is necessary for appropriate man-
agement of patients who have had lung transplants.
Currently, biopsy is the most reliable technique in mak-
ing the diagnosis of rejection clinically. A noninvasive,
clinically reliable technique for detection of acute and
chronic rejection has been sought since none of the pre-
viously proposed methods have been widely accepted.
We previously reported that T cells labeled with
USPIO particles in vitro8,9 could be detected in vivo
with MRI,10 giving rise to the possibility of a noninva-
sive method to detect rejection. Both T cells and
macrophages are involved in the process of acute rejec-
tion, as demonstrated immunohistologically. Here, we
have shown an approach to detect acute lung rejection
with MRI, using macrophages labeled with USPIO
particles in vivo. The ability of macrophages to ingest
USPIO particles in vitro was 8 to 16 times higher than
that of T cells (see Fig 1 and reference 8). The in vivo
ability of macrophages to ingest USPIO was also high-
er than that of T cells, as indicated by the distribution
of iron staining in ED1+ cells and CD3+ cells. Since
MR signal changes are detected more effectively when
labeled macrophages are used, it is reasonable to use
labeled macrophages for tracking cell migration in vivo
with MRI for the purpose of detecting rejection. This
labeling procedure readily shows a difference in the
MR signal intensity between allograft and isograft and
appears to have an excellent correlation with the patho-
logic rejection grade.
Although this noninvasive MRI technique is
promising, there are inherent limitations. First, be-
cause USPIO particles are primarily ingested by
macrophages, it remains unclear whether this tech-
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Fig 7. Immunohistologic counts of CD3+ or ED1+ cells. The CD3+ or ED1+ cells were counted in at least 10 fields
per section per rat (n = 6 in each group). The fields were randomly chosen and counting was performed in a blind-
ed manner at a magnification of ×100. Data are presented as mean ± standard deviation of the mean.
nique can distinguish between infection and rejection
processes, both of which involve macrophages.
Further investigation is necessary to elucidate and
overcome this limitation. Since USPIO particles are
primarily taken up by macrophages and much less by
T cells (the labeling efficiency for macrophages is
~80% vs ~20% for T cells8), the MRI results may not
fully reflect the antigen-specific immunologic
response of T cells. In addition, it is quite difficult to
obtain clear lung MR images with current MR tech-
niques. Imaging needs to be improved before our
methods can be applied clinically.
Despite these limitations, in vivo labeling of
macrophages does offer a potential clinical application
for detection of organ rejection. A number of noninva-
sive approaches for detecting organ transplant rejection
have been proposed. However, none of these approach-
es has been accepted for clinical use. The MRI method
that we have demonstrated here may be a first step
toward a clinical application.
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Fig 8. Histologic and immunohistochemical analyses of an allograft. Perls’ Prussian blue reaction shows the distribu-
tion of the iron-containing cells (A). B and C show ED1+ or CD3+ cells, respectively. Comparing B with A, the distri-
bution of the iron-containing cells completely correlates with the presence of ED1+ cells, whereas, comparing C with
A, the distribution of CD3+ cells does not correlate with that of iron staining. Figures were at a magnification of ×100.
We thank Dr Donald S. Williams and Dr E. Ann Pratt for
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Discussion
Dr Steven J. Mentzer (Boston, Mass). This study extends
this group’s previous work using iron oxide particles from the
labeling of single cells to the labeling of cells infiltrating a
rejecting allograft. It is a first step toward a future in which a
noninvasive scan can provide both an anatomic and potential-
ly a functional assessment of the inflammatory reaction. How
convenient it would be to send our patients for a scan to diag-
nose acute rejection. 
At present, however, there appear to be several obstacles to
a noninvasive diagnosis of allograft rejection. I would like Dr
Kanno to address 3 of these obstacles. First, the lung is noto-
riously difficult to image by means of conventional proton
MRI, primarily because of the air and the inhomogeneity of
the lung parenchyma. MRI scans of the lung frequently look
dark, with poor anatomic resolution. In your studies, the iron
oxide particles appear to further darken the regions of inter-
est. How limiting are these lung-specific characteristics, and
do you think this technique might be better applied to other
organs? 
Second, T cells are generally thought to play a dominant
role in antigen-specific allograft rejection. T cells, as demon-
strated by your group’s previous work, also take up the iron
particles. Macrophages, on the other hand, are intimately
involved in many different types of unrelated inflammatory
reactions. Do you have any plans to more specifically target
the T-cell component of the inflammatory reaction? 
Third, an advantage of using an inguinal model of lung
transplantation is that there is no movement in the lung, yet
you used electrocardiographic gating of the scan. Do you see
respiratory movement as a potential limitation of these scans
when applied to the diagnosis of acute lung rejection? 
The ultimate goal of any diagnostic test of acute transplant
rejection is the ability to discriminate between infection and
rejection. The authors appropriately note that this objective
remains in the future; nonetheless, I congratulate them for
taking a creative and thoughtful step toward this goal. 
Dr Thomas M. Egan (Chapel Hill, NC). It is an interest-
ing study. Do you know how specific the findings are? Have
you done any studies in lungs that are infected rather than
lungs that are rejecting? My suspicion is that you would have
increased macrophage numbers and therefore a positive scan.
From a clinical standpoint, that is usually the problem: dif-
ferentiating rejection from infection. 
Dr Malcolm M. DeCamp (Cleveland, Ohio). Addressing
the specificity of this technique to look for allograft rejection,
could you also comment on how you could use it to discrim-
inate ischemia/reperfusion injury and other global inflamma-
tory changes from specific immune inflammatory changes? 
The histologic hallmark of cell-mediated acute rejection is
an angiocentric lymphocytic response, yet the macrophages
did not appear necessarily to be oriented around the vessels.
Could you comment on the dissociation between the T cells
that seemed to be infiltrating the biopsy specimens and the
iron-labeled macrophages on your photomicrographs? 
Dr Kanno. Thank you for your comments. 
The conventional MRI technique for lung imaging is very
difficult, so in this work we collapsed the lungs. However,
now we are trying to do orthotopic lung transplantation in the
rat with ventilated lungs, and we are trying to take MR
images by using 100% oxygen as a contrast agent. This is
very preliminary, but we were successful in distinguishing
macrophage infiltration even in the ventilated lung. Of
course, we need to improve our MRI technique for the lung.
Regarding T cells and macrophages, the macrophage has
a very nonspecific infiltration into the lung, even in infec-
tion and rejection. We first used T-cell labeling with USPIO
particles, but the labeling efficiency of T cells is very low
compared with that of macrophages. That may be the rea-
son that the distribution of T cells is not correlated with
that of USPIO particles in the pathologic slides. Therefore,
we changed to using macrophages for targeting and track-
ing by MRI. This is also preliminary, but the distribution of
the macrophages in infection and rejection is somewhat
different in MR images. The next step for us in differenti-
ating infection from rejection is looking for the distribution
changes in MR images, but this is a very challenging task.
Our preliminary results indicate that reperfusion injury is
different from rejection in the distribution of the
macrophages. We still have to do many things to distin-
guish rejection from infection or reperfusion injury.
934 Kanno et al The Journal of Thoracic and
Cardiovascular Surgery
November 2000
